Get in Touch With Us
Revenue Growth: Net revenue increased by 4% to ₹442.71 crore, up from ₹425.00 crore in Q2 FY24.
EBITDA Surge: EBITDA grew by 33%, reaching ₹49.06 crore in Q2 FY25, compared to ₹36.83 crore in Q2 FY24.
Profit After Tax (PAT): PAT surged 64% to ₹34.85 crore for Q2 FY25, up from ₹21.26 crore in the same quarter last year.
Expansion in Medical Devices: The medical devices segment revenue grew by 9.35% YoY, reaching ₹133 crore. With over 13 million glucometers installed, production expansion is underway to meet growing demand.
Pharma Segment Growth: The pharma division saw a 9% revenue increase, with export revenue up by 21%, bolstered by strong performance in Europe (up 60%) and Asia.
Strategic Investment for Future Growth: Morepen raised ₹200 crore via Qualified Institutional Placement (QIP), facilitating capacity expansions across API and medical devices.
Revenue Growth: Net revenue increased by 4% to ₹442.71 crore, up from ₹425.00 crore in Q2 FY24
EBITDA Surge: EBITDA grew by 33%, reaching ₹49.06 crore in Q2 FY25, compared to ₹36.83 crore in Q2 FY24.
Profit After Tax (PAT): PAT surged 64% to ₹34.85 crore for Q2 FY25, up from ₹21.26 crore in the same quarter last year.
Expansion in Medical Devices: The medical devices segment revenue grew by 9.35% YoY, reaching ₹133 crore. With over 13 million glucometers installed, production expansion is underway to meet growing demand.
Pharma Segment Growth: The pharma division saw a 9% revenue increase, with export revenue up by 21%, bolstered by strong performance in Europe (up 60%) and Asia.
Strategic Investment for Future Growth: Morepen raised ₹200 crore via Qualified Institutional Placement (QIP), facilitating capacity expansions across API and medical devices.
Empowering Health. Everywhere
Morepen is dedicated to providing affordable, high-quality healthcare solutions through innovative pharmaceutical and medical technology products. We strive to make health accessible for all and achieve a global reach.
Excellence. Passion. Action. Innovation
Morepen is driven by a commitment to excellence in everything we do. Our three core values – Passion, Action, and Innovation – guide our actions. We prioritize delivering superior quality products, efficient distribution networks, and exceptional customer service. We are a passionate and results-oriented team, leveraging technology for continuous research and development. Our goal is to remain at the forefront of healthcare solutions.
Annual Return
Annual Secretarial Compliance Report
Newspaper Advertisements
Investor Earning Call Q2 FY 2025
